A novel algorithm for lung adenocarcinoma based on N6 methyladenosine‐related immune long noncoding RNAs as a reliable biomarker for predicting survival outcomes and selecting sensitive anti‐tumor therapies
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24636
Abstract: Lung cancer is a highly heterogeneous malignant tumor with high incidence and mortality. Recently, increasing evidence has demonstrated that N6‐methyladenosine (m6A) methylation and the tumor microenvironment (TME) play important roles in the occurrence and development… read more here.
Keywords: lung adenocarcinoma; lung; algorithm lung; adenocarcinoma based ... See more keywords